BofA analyst Bryan Spillane raised the firm’s price target on Colgate-Palmolive to $100 from $90 and keeps a Buy rating on the shares after a “stellar Q1” that featured the company starting 2024 with better pricing and resilient volume. Following the report, the firm raised its FY24 organic sales growth estimate to 6.5% from 4.5%, mostly on higher pricing to offset incremental forex impact, with net sales largely unchanged.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- CL Earnings: Colgate-Palmolive Brushes Past Q1 Estimates
- Options Volatility and Implied Earnings Moves Today, April 26, 2024
- Colgate-Palmolive reports Q1 base gross profit margin up 310 bps to 60.0%
- Colgate-Palmolive raises FY24 net sales growth view to 2%-5% from 1%-4%
- Colgate-Palmolive reports Q1 base EPS 86c, consensus 76c
